You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Cataplexy

Showing 26 - 50 of 99
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Rare Disorders, Undiagnosed Disorders, Disorders of Unknown Prevalence Trial in Sioux Falls, Sydney

Recruiting
  • Rare Disorders
  • +309 more
    • Sioux Falls, South Dakota
    • +1 more
    Jun 20, 2022

    Pediatric Narcolepsy Patient Reported Outcomes Scale

    Recruiting
    • Narcolepsy
    • Obstructive Sleep Apnea
      • Boston, Massachusetts
        Boston Children's Hospital
      May 26, 2022

      Narcolepsy Type 1 (NT1), Narcolepsy Type 2 (NT2) Trial in Worldwide (TAK-994, Placebo)

      Terminated
      • Narcolepsy Type 1 (NT1)
      • Narcolepsy Type 2 (NT2)
      • Alabaster, Alabama
      • +77 more
      Oct 5, 2022

      Narcolepsy Type 1 (NT 1) Trial in Worldwide (TAK-994, Placebo)

      Terminated
      • Narcolepsy Type 1 (NT 1)
      • Alabaster, Alabama
      • +69 more
      Oct 5, 2022

      Narcolepsy With Cataplexy Trial in Worldwide (Xyrem)

      Completed
      Has Results
      • Narcolepsy With Cataplexy
      • Long Beach, California
      • +19 more
      Apr 26, 2019

      A Patient-Centric, Prospective, Observational,

      Completed
      • Narcolepsy
      • Transition from Xyrem to Xywav
      • Palo Alto, California
        Jazz Pharmaceuticals Clinical Site
      Jun 27, 2022

      Narcolepsy Without Cataplexy, Narcolepsy With Cataplexy Trial in United States (Pitolisant)

      No longer available
      • Narcolepsy Without Cataplexy
      • Narcolepsy With Cataplexy
      • Birmingham, Alabama
      • +70 more
      Aug 22, 2019

      Narcolepsy Type 1 Trial in St.Gallen (Group psychotherapy)

      Recruiting
      • Narcolepsy Type 1
      • Group psychotherapy
      • St.Gallen, Switzerland
        Clinic for Psychosomatic Medicine, Cantonal Hospital St.Gallen
      Jun 2, 2022

      Safety of DAYVIGO (Lemborexant) Tablets in Insomnia.

      Completed
      • Sleep Initiation and Maintenance Disorders
      • Nagoya, Japan
      • +2 more
      Apr 4, 2022

      Narcolepsy Trial in United States (JZP-258)

      Recruiting
      • Narcolepsy
      • Alabaster, Alabama
      • +27 more
      Jul 22, 2022

      Major Depressive Disorder Who Have HadInadequate Response

      Terminated
      • Depressive Disorder, Major
      • Standard of Care (SOC)
      • San Francisco, California
      • +3 more
      Dec 6, 2022

      Narcolepsy, Social Cognition Trial in Amiens (Questionary)

      Recruiting
      • Narcolepsy
      • Social Cognition
      • Questionary
      • Amiens, France
        CHU Amiens-Picardie
      Mar 17, 2023

      Depressive Disorder, Major Trial in Worldwide (Seltorexant, Placebo)

      Recruiting
      • Depressive Disorder, Major
      • Phoenix, Arizona
      • +145 more
      Jan 31, 2023

      Idiopathic Hypersomnia, Narcolepsy Without Cataplexy Trial in United States (BTD-001, Placebo)

      Completed
      • Idiopathic Hypersomnia
      • Narcolepsy Without Cataplexy
      • Birmingham, Alabama
      • +22 more
      Jan 14, 2019

      Narcolepsy Trial in Belgium, France (Active comparator: Modafinil + , THN102 300/3, THN102 300/27)

      Completed
      Has Results
      • Narcolepsy
      • Active comparator: Modafinil + placebo
      • +2 more
      • Erpent, Belgium
      • +7 more
      Aug 18, 2020

      Clinical Phenotypes and Outcomes of Ma2 Patient

      Completed
      • Autoimmune Encephalitis
      • Paraneoplastic Syndromes
      • Diagnosis test
      • Lyon, France
        Centre de référence des syndromes neurologiques paranéoplasiques
      Dec 8, 2022

      A Multi-Signal Based Monitoring System for CNS Hypersomnias

      Recruiting
      • Hypersomnia
        • Taoyuan City, Taiwan
        • +1 more
        Jun 30, 2022

        Orexin-A, HLA Gene, PSG and MSLT in the Evaluation of Narcolepsy

        Enrolling by invitation
        • Narcolepsy
          • Jinan, Shandong, China
            The First Affiliated Hospital of Shandong First Medical Universi
          Jun 23, 2021

          Depressive Disorder, Major Trial in Worldwide (Seltorexant, Placebo)

          Recruiting
          • Depressive Disorder, Major
          • San Diego, California
          • +26 more
          Aug 17, 2022

          Narcolepsy 1, Idiopathic Hypersomnia Trial in Zürich (Sleep restriction, Sleep deprivation)

          Completed
          • Narcolepsy 1
          • Idiopathic Hypersomnia
          • Sleep restriction
          • Sleep deprivation
          • Zürich, Switzerland
            University Hospital Zurich
          Feb 19, 2021

          Sleep Apnea, Obstructive Trial in United States (Seltorexant 40 mg, Placebo)

          Completed
          • Sleep Apnea, Obstructive
          • Seltorexant 40 mg
          • Placebo
          • Atlanta, Georgia
          • +3 more
          Jun 9, 2022

          Narcolepsy, Cataplexy Trial in Clermont-Ferrand (fMRI, Videopolysomnography, NC (narcolepsy-cataplexy))

          Unknown status
          • Narcolepsy
          • Cataplexy
          • fMRI
          • +2 more
          • Clermont-Ferrand, France
            CHU Clermont-Ferrand
          Feb 8, 2018

          Healthy Trial in Salt Lake City (Seltorexant)

          Completed
          • Healthy
          • Salt Lake City, Utah
            PRA Health Sciences
          Apr 22, 2021

          Alpha-synuclein RT-QuIC Assay asDiagnostic Technique in REM

          Suspended
          • Sleep Disorder Rem Sleep Behavior
          • Parkinson's Disease, Lewy Body
          • No Intervention
          • Edinburgh, Lothian, United Kingdom
            The University of Edinburgh
          May 17, 2021

          PTSD Trial in United States (losartan, Placebo)

          Completed
          Has Results
          • Posttraumatic Stress Disorder
          • La Jolla, California
          • +5 more
          Feb 19, 2021